Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy.

Fechete R, Heinzel A, Perco P, Mönks K, Söllner J, Stelzer G, Eder S, Lancet D, Oberbauer R, Mayer G, Mayer B.

Proteomics Clin Appl. 2011 Jun;5(5-6):354-66. doi: 10.1002/prca.201000136. Epub 2011 Apr 14.

PMID:
21491608
2.

Systems biology: building a useful model from multiple markers and profiles.

Mayer P, Mayer B, Mayer G.

Nephrol Dial Transplant. 2012 Nov;27(11):3995-4002. doi: 10.1093/ndt/gfs489. Review.

PMID:
23144070
3.

Data mining methods in Omics-based biomarker discovery.

Zhang F, Chen JY.

Methods Mol Biol. 2011;719:511-26. doi: 10.1007/978-1-61779-027-0_24.

PMID:
21370100
4.

Searching for novel biomarkers and new therapeutic targets of diabetic nephropathy using proteomics approaches.

Thongboonkerd V.

Contrib Nephrol. 2008;160:37-52. doi: 10.1159/000125928. Review.

PMID:
18401160
5.

Biomarkers of diabetic nephropathy, the present and the future.

Jim B, Santos J, Spath F, Cijiang He J.

Curr Diabetes Rev. 2012 Sep;8(5):317-28. Review.

PMID:
22698077
6.

[Novel biomarkers for diabetic nephropathy].

Araki S.

Rinsho Byori. 2014 Feb;62(2):171-9. Review. Japanese.

PMID:
24800493
7.

Study of diabetic nephropathy in the proteomic era.

Thongboonkerd V.

Contrib Nephrol. 2011;170:172-83. doi: 10.1159/000325657. Epub 2011 Jun 9. Review.

PMID:
21659770
8.

Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?

Papale M, Di Paolo S, Vocino G, Rocchetti MT, Gesualdo L.

J Nephrol. 2014 Jun;27(3):221-8. doi: 10.1007/s40620-014-0044-5. Epub 2014 Feb 25. Review. Erratum in: J Nephrol. 2014 Aug;27(4):465-6.

PMID:
24567069
9.

Proteomics and diabetic nephropathy.

Merchant ML, Klein JB.

Curr Diab Rep. 2005 Dec;5(6):464-9. Review.

PMID:
16316599
10.

Proteomics in gerontology: current applications and future aspects--a mini-review.

Schiffer E, Mischak H, Zimmerli LU.

Gerontology. 2009;55(2):123-37. doi: 10.1159/000191653. Epub 2009 Jan 9. Review.

PMID:
19136815
11.

New insights into the use of biomarkers of diabetic nephropathy.

Jha JC, Jandeleit-Dahm KA, Cooper ME.

Adv Chronic Kidney Dis. 2014 May;21(3):318-26. doi: 10.1053/j.ackd.2014.03.008. Review.

PMID:
24780461
12.

Practical bioinformatics for proteomics.

Thongboonkerd V, Klein JB.

Contrib Nephrol. 2004;141:79-92. Review.

PMID:
14650226
13.

Molecular disease presentation in diabetic nephropathy.

Heinzel A, Mühlberger I, Stelzer G, Lancet D, Oberbauer R, Martin M, Perco P.

Nephrol Dial Transplant. 2015 Aug;30 Suppl 4:iv17-25. doi: 10.1093/ndt/gfv267. Review.

PMID:
26209734
14.

Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.

Steinke JM, Mauer M; International Diabetic Nephropathy Study Group.

Pediatr Endocrinol Rev. 2008 Aug;5 Suppl 4:958-63. Review.

PMID:
18806710
15.

Bone morphogenetic protein-7 and Gremlin: New emerging therapeutic targets for diabetic nephropathy.

Zhang Y, Zhang Q.

Biochem Biophys Res Commun. 2009 May 22;383(1):1-3. doi: 10.1016/j.bbrc.2009.03.086. Epub 2009 Mar 19. Review.

PMID:
19303394
16.

[Potential therapeutic targets for diabetic nephropathy].

Makino Y, Haneda M.

Nihon Rinsho. 2009 Aug;67(8):1627-35. Review. Japanese.

PMID:
19768953
17.

Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis.

Aschauer C, Perco P, Heinzel A, Sunzenauer J, Oberbauer R.

PLoS One. 2017 Jan 6;12(1):e0169518. doi: 10.1371/journal.pone.0169518. eCollection 2017.

18.

Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring.

Rossing K.

Dan Med Bull. 2007 May;54(2):79-98. Review. No abstract available.

PMID:
17521525
19.

Diagnostic markers for early detection of diabetic retinopathy and nephropathy.

Futrakul N, Futrakul P.

Clin Nephrol. 2008 Jan;69(1):63-4. No abstract available.

PMID:
18218319
20.

Proteomics and systems biology for understanding diabetic nephropathy.

Starkey JM, Tilton RG.

J Cardiovasc Transl Res. 2012 Aug;5(4):479-90. doi: 10.1007/s12265-012-9372-9. Epub 2012 May 12. Review.

Supplemental Content

Support Center